Format
Sort by

Send to

Choose Destination

Search results

Items: 11

1.

A case-matched study of toxicity outcomes after proton therapy and intensity-modulated radiation therapy for prostate cancer.

Fang P, Mick R, Deville C, Both S, Bekelman JE, Christodouleas JP, Guzzo TJ, Tochner Z, Hahn SM, Vapiwala N.

Cancer. 2015 Apr 1;121(7):1118-27. doi: 10.1002/cncr.29148. Epub 2014 Nov 25.

2.

Results and DVH analysis of late rectal bleeding in patients treated with 3D-CRT or IMRT for localized prostate cancer.

Someya M, Hori M, Tateoka K, Nakata K, Takagi M, Saito M, Hirokawa N, Hareyama M, Sakata K.

J Radiat Res. 2015 Jan;56(1):122-7. doi: 10.1093/jrr/rru080. Epub 2014 Sep 11.

3.

Ion Prostate Irradiation (IPI) - a pilot study to establish the safety and feasibility of primary hypofractionated irradiation of the prostate with protons and carbon ions in a raster scan technique.

Habl G, Hatiboglu G, Edler L, Uhl M, Krause S, Roethke M, Schlemmer HP, Hadaschik B, Debus J, Herfarth K.

BMC Cancer. 2014 Mar 19;14:202. doi: 10.1186/1471-2407-14-202.

4.

Quality of life and toxicity from passively scattered and spot-scanning proton beam therapy for localized prostate cancer.

Pugh TJ, Munsell MF, Choi S, Nguyen QN, Mathai B, Zhu XR, Sahoo N, Gillin M, Johnson JL, Amos RA, Dong L, Mahmood U, Kuban DA, Frank SJ, Hoffman KE, McGuire SE, Lee AK.

Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):946-53. doi: 10.1016/j.ijrobp.2013.08.032. Epub 2013 Oct 15.

5.

Maximizing the biological effect of proton dose delivered with scanned beams via inhomogeneous daily dose distributions.

Zeng C, Giantsoudi D, Grassberger C, Goldberg S, Niemierko A, Paganetti H, Efstathiou JA, Trofimov A.

Med Phys. 2013 May;40(5):051708. doi: 10.1118/1.4801897.

6.

Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancer.

Gray PJ, Paly JJ, Yeap BY, Sanda MG, Sandler HM, Michalski JM, Talcott JA, Coen JJ, Hamstra DA, Shipley WU, Hahn SM, Zietman AL, Bekelman JE, Efstathiou JA.

Cancer. 2013 May 1;119(9):1729-35. doi: 10.1002/cncr.27956. Epub 2013 Feb 22.

7.

Hypofractionated proton boost combined with external beam radiotherapy for treatment of localized prostate cancer.

Johansson S, Aström L, Sandin F, Isacsson U, Montelius A, Turesson I.

Prostate Cancer. 2012;2012:654861. doi: 10.1155/2012/654861. Epub 2012 Jul 8.

8.

Influence of robust optimization in intensity-modulated proton therapy with different dose delivery techniques.

Liu W, Li Y, Li X, Cao W, Zhang X.

Med Phys. 2012 Jun;39(6):3089-101. doi: 10.1118/1.4711909.

9.

Proton therapy in clinical practice.

Liu H, Chang JY.

Chin J Cancer. 2011 May;30(5):315-26. Review.

10.

Interfractional variations in the setup of pelvic bony anatomy and soft tissue, and their implications on the delivery of proton therapy for localized prostate cancer.

Trofimov A, Nguyen PL, Efstathiou JA, Wang Y, Lu HM, Engelsman M, Merrick S, Cheng CW, Wong JR, Zietman AL.

Int J Radiat Oncol Biol Phys. 2011 Jul 1;80(3):928-37. doi: 10.1016/j.ijrobp.2010.08.006. Epub 2010 Oct 13.

11.
Items per page

Supplemental Content

Loading ...
Write to the Help Desk